Get email updates from SABCSMeetingNews.org
Subscribe to get regular news updates from SABCS.org and SABCS Meeting News.
Melinda L. Telli, MD, will deliver the second plenary lecture at the 2023 SABCS® on how the emergence of immunotherapy and antibody drug conjugation has changed the field of triple-negative breast cancer and increased options for patients.
The 2023 SABCS® will feature multiple presentations on breast cancer risk reduction and prevention, including a discussion of obesity-associated breast cancer risk moderated by Abenaa M. Brewster, MD, MHS.
Komal Jhaveri, MD, FACP, will moderate a lightning-quick discussion of challenging or controversial topics, including low-dose tamoxifen, window-of-opportunity trials, and tumor sequencing timing.
Joanne Kotsopoulos, MSc, PhD, discusses her Tuesday, December 5, presentation on cancer risk associated with exogenous hormone use in BRCA mutation carriers.
Barbara Segarra-Vazquez, DHSc, discusses her Tuesday, December 5, presentation on screening for health-related social needs.